Topical Trifarotene: A New Retinoid Topical Trifarotene: A New Retinoid
Trifarotene, a novel fourth-generation topical retinoid, shows favorable preliminary efficacy for acne, and may offer better tolerability than currently available drugs in this class.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 24, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Monitoring of Spitz/Reed Nevi in Children Questioned Monitoring of Spitz/Reed Nevi in Children Questioned
Authors of a research letter question recent guidelines stating that any spitzoid-looking lesion in children under age 12 should be monitored.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

Medical News Today: How to identify a chlorine rash
Some people develop a rash after swimming in chlorinated pools or soaking in hot tubs. Chlorine rash is simple to treat, but can be confused with other rashes, such as swimmer's itch and heat rash. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 21, 2018 Category: Consumer Health News Tags: Dermatology Source Type: news

Why an Exton pharma firm will benefit from Almirral's $550M deal with Allergan
Almirall SA has finalized its $550 million acquisition of four approved products and one new drug candidate from Allergan's medical dermatology unit in  the United States. The acquisition bolsters the presence of Almirall, which is based in Barcelona, Spain, in the U.S. dermatology market through its Exton-based subsidiary Aqua Pharmaceuticals. Almirall acquired Aqua in 2013 in a deal valued at up to $400 million. Aqua makes and markets a variet y of product for skin disorders including acne, eczema,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2018 Category: Biotechnology Authors: John George Source Type: news

Almirall acquires Allergan U.S. medical dermatology portfolio*
Portfolio includes four available therapies for acne and dermatoses and an investigational compound currently under FDA review Agreement enhances Almirall's portfolio in the U.S. and emphasizes long-term commitment to the dermatology community EXTON,... Biopharmaceuticals, Dermatology, Acquisitions Almirall, Allergan, Aczone, Tazorac, Azelex, Cordran (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Manage Poison Ivy Rash
Title: Health Tip: Manage Poison Ivy RashCategory: Health NewsCreated: 9/21/2018 12:00:00 AMLast Editorial Review: 9/21/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 21, 2018 Category: Dermatology Source Type: news

Health Tip: Help Prevent Varicose and Spider Veins
Title: Health Tip: Help Prevent Varicose and Spider VeinsCategory: Health NewsCreated: 9/21/2018 12:00:00 AMLast Editorial Review: 9/21/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 21, 2018 Category: Dermatology Source Type: news

Alitretinoin for Management of Chronic Hand Dermatitis Alitretinoin for Management of Chronic Hand Dermatitis
This article summarizes real-world evidence supporting the safety and effectiveness of alitretinoin, an oral retinoid, in the management of chronic hand dermatitis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Sirolimus Add-On Seen Helpful for Visible Arteriovenous Malformations
(MedPage Today) -- Small case series suggests favorable outcomes in otherwise difficult cases (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 21, 2018 Category: Dermatology Source Type: news

Research Links Doctor Burnout to Patient Safety Incidents
Physician burnout linked to increased risk of patient safety incidents, reduced patient satisfaction (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 21, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Residents Should Take Advantage of Paid Time Off
Residents report making time for family, pursuing interests, and squeezing in important trips (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 20, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Why Eczema Is Tougher to Treat for Black Patients
Title: Why Eczema Is Tougher to Treat for Black PatientsCategory: Health NewsCreated: 9/19/2018 12:00:00 AMLast Editorial Review: 9/20/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 20, 2018 Category: Dermatology Source Type: news

Molecular Phenotype of Atopic Dermatitis Varies by Ethnicity Molecular Phenotype of Atopic Dermatitis Varies by Ethnicity
Atopic dermatitis (AD) is TH2-TH22-biased in African Americans (AAs) compared to European Americans (EAs), while TH1/TH17 is attenuated, according to the first global molecular-profiling study of AA AD using RNA-seq.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 20, 2018 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Korea ’ s Hironic wins FDA nod for AFit laser acne device
Korean skin care device developer Hironic has won FDA approval for its AFit laser device intended to treat acne. The AFit device features a 1450 nm diode laser designed to penetrated into the dermal and subcutaneous layers. The system also features a bipolar radiofrequency and Cryogen cooling device, the company said. “AFit’s FDA approval has a great significance in that it has established a bridge for entry into the United States, which is the largest market in the global cosmetic medical device, with a share of nearly 50%. Other equipments that are under FDA approval will also be affected,” CEO Jinwoo L...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cosmetic/Aesthetic Food & Drug Administration (FDA) Regulatory/Compliance hironic Source Type: news

Rosacea: 5 Things to Know Rosacea: 5 Things to Know
These five things include some lesser known, but critically important, facts about rosacea and its management.Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Dermatology Viewpoint Source Type: news

Dupilumab Effective in Teens With Moderate to Severe Eczema Dupilumab Effective in Teens With Moderate to Severe Eczema
The drug, approved for adults with moderate to severe atopic dermatitis, is effective in a younger population, which has few reliable options, data from a phase 3 study show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

20 % of Children, Adolescents Use Prescription Medications
8.2 percent of concurrent users of prescription meds at risk for potentially major drug - drug interactions (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 19, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Gastroenterology, Gynecology, Infections, Nephrology, Neurology, Nursing, ENT, Pediatrics, Pharmacy, Psychiatry, Pulmonology, Urology, Anesthesiology & amp; Pain, Allergy, Emergency Medicine, Jo Source Type: news

Patient Health Information Often Shared Electronically
Most commonly observed types of PHI sent are referrals, laboratory results, medication lists (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 19, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Why Eczema Is Tougher to Treat for Black Patients
WEDNESDAY, Sept. 19, 2018 -- Eczema, or atopic dermatitis, can be very difficult to control in some people. But the skin condition, which leads to dry, itchy and inflamed skin, is particularly problematic for black people, according to new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 19, 2018 Category: General Medicine Source Type: news

Review: Treatments for Primary Basal Cell Carcinoma Compared
Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external - beam radiation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 18, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

Drug Prices Increase More Than Expected After Shortages
Expected price increase 20 percent for all drugs after shortage versus 9 percent in absence of shortage (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Compliance With Requirement to Report Results on EUCTR Is Poor
Half of trials on European Union Clinical Trials Register are non - compliant with requirements (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

People With Psoriasis Often Face Stigma, Discrimination People With Psoriasis Often Face Stigma, Discrimination
People with psoriasis are often faced with people who don't want to shake hands with them and who see them - incorrectly - as contagious, according to a new study.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 18, 2018 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Make the Diagnosis: A Skin Fold Wrinkle
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 17, 2018 Category: Dermatology Source Type: news

JAK Inhibitors Promising for Alopecia Areata JAK Inhibitors Promising for Alopecia Areata
Two investigational new drugs are emerging for patients with moderate to severe hair loss, for whom there are currently no reliable treatments.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 17, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

Association Health Plans Can Help Small Businesses Offer Coverage
But AHPs may undermine ACA marketplace, as they are not required to comply with ACA regulations (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 17, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Mixed Results with Reduced-Dose Psoriasis Tx
(MedPage Today) -- Null trial but most patients do well on lower dose of biological (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 17, 2018 Category: Dermatology Source Type: news

U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019 DULUTH, Ga., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U... Devices, Dermatology, FDA Sebacia, Sebacia Microparticles, acne (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

JAK Agents Impress in Alopecia Areata
(MedPage Today) -- Significant hair growth with two different drugs (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 17, 2018 Category: Dermatology Source Type: news

Geographic Disparities Seen in Distribution of Dermatologists
MONDAY, Sept. 17, 2018 -- There are substantial disparities in the geographic distribution of dermatologists that are worsening with time, according to a study published online Sept. 5 in JAMA Dermatology. Hao Feng, M.D., from New York University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 17, 2018 Category: Pharmaceuticals Source Type: news

A Multistep Algorithm to Detect In Situ Melanomas A Multistep Algorithm to Detect In Situ Melanomas
The authors present a multistep diagnostic algorithm for in situ melanoma detection using reflectance confocal microscopy combined with dermoscopy.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Even With More U.S. Dermatologists, Rural Patients May Lack Access Even With More U.S. Dermatologists, Rural Patients May Lack Access
The number of dermatologists per capita in the U.S. has surged more than 20 percent since the mid-90s, but a new study suggests access to care may have improved more in cities than in rural areas.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 16, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

Eczema: Watch out for these six types of the itchy skin condition
ECZEMA is the name for a group of skin conditions that cause dry, irritated skin. The most common type of eczema, which is most often associated with the general term, is atopic dermatitis, or atopic eczema. However, there are also other forms of eczema, which have differing symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - September 16, 2018 Category: Consumer Health News Source Type: news

Methotrexate Effective in Subcutaneous Psoriasis
(MedPage Today) -- Over 40% of patients achieved PASI 75 response in 16-week trial (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 15, 2018 Category: Dermatology Source Type: news

Subq Methotrexate Effective in Psoriasis
(MedPage Today) -- Over 40% of patients achieved PASI 75 response in 16-week trial (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 15, 2018 Category: Dermatology Source Type: news

Global Estimates Belittle Burden of Skin Diseases Global Estimates Belittle Burden of Skin Diseases
A patient-driven project is underway to accurately measure skin diseases around the world so that melanoma and psoriasis are not rated as being less problematic than gout.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

Risankizumab Effective for Moderate to Severe Psoriasis Risankizumab Effective for Moderate to Severe Psoriasis
Response rates with the novel biologic that targets IL-23 are strong, even among obese patients, and the dosing interval is attractive, but the treatment field for plaque psoriasis is already crowded.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news

Situation Framing, Language Can Influence Decision - Making
Docs should provide risks of both having treatment and not having treatment to minimize loss aversion (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 14, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Serious Infection Risk with Biologics for Atopic Dermatitis
(MedPage Today) -- Double the risk associated with systemic nonbiologics (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 14, 2018 Category: Infectious Diseases Source Type: news

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline DUBLIN and NEWPORT BEACH, Calif., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc ... Biopharmaceuticals, Dermatology, Mergers & Acquisitions Allergan, Bonti, botulinum neurotoxin, BoNT/E, botulinum (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2018 Category: Pharmaceuticals Source Type: news

Topical JAK Inhibitor Active in Atopic Dermatitis
(MedPage Today) -- Significant improvement in multiple endpoints after 4 weeks with ruxolitinib cream (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 14, 2018 Category: Dermatology Source Type: news

New Mexico Patrons of 'Vampire Facial' Spa May Have Been Exposed to HIV
Title: New Mexico Patrons of 'Vampire Facial' Spa May Have Been Exposed to HIVCategory: Health NewsCreated: 9/14/2018 12:00:00 AMLast Editorial Review: 9/14/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 14, 2018 Category: Dermatology Source Type: news

New study shows eczema in African-Americans is more difficult to treat
(American College of Allergy, Asthma, and Immunology) A new study suggests that African-Americans may face a greater struggle to find effective therapies for atopic dermatitis than European-Americans. The study used molecular profiling to study the skin of both groups. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2018 Category: International Medicine & Public Health Source Type: news

Even with more U.S. dermatologists, rural patients may lack access
(Reuters Health) - The number of dermatologists per capita in the U.S. has surged more than 20 percent since the mid-90s, but a new study suggests access to care may have improved more in cities than in rural areas. (Source: Reuters: Health)
Source: Reuters: Health - September 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
However, in post - ACA era, lesbian, gay, bisexual adults still report trouble affording care (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 13, 2018 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Pooled analyses from ultIMMa-1 and ultIMMa-2 studies showed significantly more patients treated with risankizumab were symptom-free (psoriasis symptom scale [PSS] score of 0) compared to placebo and STELARA® (ustekinumab) after 16 weeks and at one year... Biopharmaceuticals, Dermatology AbbVie, Risankizumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

tretinoin (Retin-A, Retin-A Micro, Atralin, Renova, Avita)
Title: tretinoin (Retin-A, Retin-A Micro, Atralin, Renova, Avita)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/13/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 13, 2018 Category: Dermatology Source Type: news

Six - Step Analysis Can Help Improve Practice Logistics
Method showed unfavorable traits related to match between supply, demand, access at outpatient clinic (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 12, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Acne Advice for Returning Students
Title: Acne Advice for Returning StudentsCategory: Health NewsCreated: 9/11/2018 12:00:00 AMLast Editorial Review: 9/12/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 12, 2018 Category: Dermatology Source Type: news

Cyltezo-Phase III -in Psoriasis
Biosimilar Cyltezo ® demonstrates clinical equivalence to Humira® in patients with moderate-to-severe plaque psoriasisData show that Cyltezo © (adalimumab- adbm) and Humira®* have similar efficacy, safety and immunogenicity in people with moderate-to-severe chronic plaque psoriasis1At week 16, the study met the primary endpoint, demonstrating clinical equivalence to Humira ®1Data will be presented at the European Association of Dermatology and Venereology Annual Meeting (EADV 2018) (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 12, 2018 Category: Research Source Type: news